Overview

Effects of Acthar on Recovery From Cognitive Relapses in MS

Status:
Completed
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of a medication called Acthar on recovery from multiple sclerosis-related relapses that impact cognition.
Phase:
Phase 3
Details
Lead Sponsor:
State University of New York at Buffalo
Treatments:
Adrenocorticotropic Hormone
beta-Endorphin
Hormones
Melanocyte-Stimulating Hormones